Abstract
This study was aimed to evaluate the effect of 124I-labeling with hexadecyl-4-iodobenzoate (HIB) on gene expression related to cell cycle, DNA repair, transcription, proliferation and differentiation of adipose-derived stem cells (ADSCs). [124I]HIB showed high labeling efficiency with ADSCs (51.3±1.3%, 0.3-2.0Bq/cell) and there is no morphological change of ADSCs. In the microarray analysis of gene expression pattern, differences were not observed between non-labeled and [124I]HIB-labeled ADSCs. We demonstrated that 124I-labeling with HIB did not affect the biological properties of ADSCs.
| Original language | English |
|---|---|
| Pages (from-to) | 116-123 |
| Number of pages | 8 |
| Journal | Applied Radiation and Isotopes |
| Volume | 108 |
| DOIs | |
| Publication status | Published - 2016 Feb 1 |
Bibliographical note
Publisher Copyright:© 2015 Elsevier Ltd.
Keywords
- Adipose-derived stem cells
- Direct labeling agent
- Hexadecyl-4-[I]iodobenzoate
- Microarray
- Myocardial infarction
ASJC Scopus subject areas
- Radiation
Fingerprint
Dive into the research topics of 'Evaluation of safety and efficacy of adipose-derived stem cells in rat myocardial infarction model using hexadecyl-4-[124I]iodobenzoate for cell tracking'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS